NOTICE IS HEREBY GIVEN that on 28 June 2023 an application was made under section 107(1) of the Financial Services and Markets Act 2000 (the “Act”) in the High Court of Justice, Business and Property Courts, Companies Court (ChD) of England and Wales (the “Court”) by the above-named Aetna Insurance Company Limited (“Aetna” or the “Transferor”), whose registered office is at The Hub, Fowler Avenue, Farnborough Business Park, Farnborough, Hampshire, England, GU14 7JF and AWP P&C SA, which is part of the Allianz group (“Allianz” or the “Transferee”), whose registered office is at 7 Rue Dora Maar, 93400, Saint-Ouen, Paris, France and who operates in the United Kingdom through a branch with registered branch number BR015275 and a registered office at Mondial House 102 George Street, Croydon, Surrey CR9 6HD for:
(1) an Order under section 111(1) of the Act sanctioning an insurance business transfer scheme (the “Scheme”) for the transfer to the Transferee of the entire insurance and reinsurance business of the Transferor (other than business written by the Singapore branch of the Transferor), namely international private medical insurance (the “Transferring Business”); and
(2) the making of ancillary provisions under section 112 of the Act in connection with the Scheme.
The proposed Scheme will result in the Transferring Business which is currently being carried on by Aetna Insurance Company Limited (FCA reference number 458505) being carried on by AWP P&C SA. The Transferring Business will be allocated in full to Allianz’s UK branch (FCA reference number 534384). If the Scheme is sanctioned, it is expected to come into effect on 1 December 2023.
Further information about the Scheme, including the documents listed below, are available and may be downloaded free of charge from www.aetnainternational.com/en/about-us/insurance_business_transfer/uk_i… or requested by email to [email protected], in writing to Aetna Insurance Company Limited, The Hub, Fowler Avenue, Farnborough Business Park, Farnborough, Hampshire, England, GU14 7JF (Attention: AICL Part VII Team) or by telephone on UK freephone 0800-085-2596 or International number +44-203-788-3288 or in person between 9am - 5pm (London time), Monday to Friday, at PwC UK, 7 More London Place, London, SE1 2RT at any time until the making of an order sanctioning the Transfer:
- a copy of the full Scheme document;
- a copy of the report on the terms of the Scheme prepared by an independent expert in accordance with section 109(1) of the Act;
- a communications pack, which includes a statement setting out the terms of the Scheme and a summary of the independent expert’s report.
For toll-free calling from other countries, please refer to https://www.business.att.com/collateral/access.html to find the number for the country you’re dialling from. When prompted during the call, please enter the access code 855-491-9150 and follow the instructions.
Supporting documents and any further news about the Scheme will be posted on this website so you may wish to check for updates.
Any questions or requests for further information regarding the proposed Scheme should be referred to Aetna and Allianz using the above details.
The Application is expected to be heard at the High Court of Justice of England and Wales, 7 Rolls Buildings, Fetter Lane, London, EC4A 1NL on 27 October 2023. Any person who considers that they may be adversely affected by the carrying out of the Scheme may appear at the Court hearing, either in person or through legal representation. It is requested that any person intending to appear at the hearing (either in person or using legal representation), please contact Aetna on UK freephone 0800-085-2596 or International number +44-203-788-3288 or in writing at the email address above as soon as possible and preferably before 20 October 2023 setting out why they believe they would be adversely affected. This will enable Aetna and Allianz to provide notification of any changes to the hearing and, where possible, to address any concerns raised in advance of the hearing. If the requested notice is not given, attendance at the Court hearing, either in person or using legal representation, will still be permitted.
Anyone who does not intend to attend the hearing but wishes to make representations about the Scheme or considers that they may be adversely affected should communicate their views to Aetna by calling or writing using the above contact details, preferably before 20 October 2023.
If the Scheme is sanctioned by the Court, it will result in the transfer of the rights and obligations under the insurance and reinsurance policies forming part of the Transferring Business to Allianz. Any right of any person to terminate, modify, acquire or claim an interest in any such policy, or to treat an interest or right in any such policy as terminated or modified, will only be enforceable if and to the extent that the order of the Court provides that it will be enforceable.
Willkie Farr and Gallagher (UK) LLP Citypoint, 1 Ropemaker Street, London, EC2Y 9AW
Solicitors to Aetna Insurance Company Limited